K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.
暂无分享,去创建一个
[1] Timothy J. Nelson,et al. Embryonic Stem Cell Therapy of Heart Failure in Genetic Cardiomyopathy , 2008, Stem cells.
[2] A. Terzic,et al. Cellular remodeling in heart failure disrupts KATP channel‐dependent stress tolerance , 2003, The EMBO journal.
[3] A. Terzic,et al. KATP channel polymorphism is associated with left ventricular size in hypertensive individuals: a large-scale community-based study , 2008, Human Genetics.
[4] Andre Terzic,et al. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells , 2007, Nature Clinical Practice Cardiovascular Medicine.
[5] Colin G. Nichols,et al. KATP channels as molecular sensors of cellular metabolism , 2006, Nature.
[6] Kenneth R Chien,et al. Regeneration next: toward heart stem cell therapeutics. , 2009, Cell stem cell.
[7] Pauline C Ng,et al. An agenda for personalized medicine. , 2009, Nature.
[8] D. K. Arrell,et al. Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.
[9] Stefanie Dimmeler,et al. Unchain my heart: the scientific foundations of cardiac repair. , 2005, The Journal of clinical investigation.
[10] Timothy J. Nelson,et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. , 2009, Circulation.
[11] C. Bearzi,et al. The Human Heart: A Self‐Renewing Organ , 2008, Clinical and translational science.
[12] A. Terzic,et al. KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart. , 2007, American journal of physiology. Heart and circulatory physiology.
[13] A. Terzic,et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. , 2004, American journal of physiology. Heart and circulatory physiology.
[14] J. Towbin,et al. The failing heart , 2002, Nature.
[15] D. Torella,et al. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration , 2006, Nature Clinical Practice Cardiovascular Medicine.
[16] Michael E Phelps,et al. Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.
[17] Samuel Bernard,et al. Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.
[18] Andre Terzic,et al. Coupling of Cell Energetics with Membrane Metabolic Sensing , 2002, The Journal of Biological Chemistry.
[19] H. Krum,et al. Demographics and concomitant disorders in heart failure , 2003, The Lancet.
[20] A. Terzic,et al. Cardiac KATP channels in health and disease. , 2005, Journal of molecular and cellular cardiology.
[21] M. Volpe,et al. Development of heart failure in recent hypertension trials , 2008, Journal of hypertension.
[22] Rona Shofti,et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells , 2004, Nature Biotechnology.
[23] D. K. Arrell,et al. Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. , 2010, Journal of molecular and cellular cardiology.
[24] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[25] R. Guyton,et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.
[26] A. Terzic,et al. Clinical and Translational Science: From Bench‐Bedside to Global Village , 2010, Clinical and translational science.
[27] Leroy Hood,et al. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.
[28] A. Terzic,et al. KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. , 2006, Human molecular genetics.
[29] D. K. Arrell,et al. Proteomic profiling of KATP channel‐deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome , 2009, Proteomics.
[30] D. K. Arrell,et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair , 2007, The Journal of experimental medicine.
[31] Susumu Seino,et al. Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics. , 2003, American journal of physiology. Heart and circulatory physiology.
[32] Frances M. Ashcroft,et al. From molecule to malady , 2006, Nature.
[33] Molecular Therapeutics From Knowledge to Delivery , 2010, Clinical pharmacology and therapeutics.
[34] Roberto Bolli,et al. Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology , 2006, Circulation.
[35] D. K. Arrell,et al. ATP‐Sensitive K+ Channel‐Deficient Dilated Cardiomyopathy Proteome Remodeled by Embryonic Stem Cell Therapy , 2010, Stem cells.
[36] T. J. Wilson,et al. M‐LDH serves as a sarcolemmal KATP channel subunit essential for cell protection against ischemia , 2002, The EMBO journal.
[37] G. Grover,et al. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs , 1990, Cardiovascular Drugs and Therapy.
[38] A. Terzic,et al. Protection conferred by myocardial ATP‐sensitive K+ channels in pressure overload‐induced congestive heart failure revealed in KCNJ11 Kir6.2‐null mutant , 2006, The Journal of physiology.
[39] Gongxin Liu,et al. Long-Chain Acyl-Coenzyme A Esters and Fatty Acids Directly Link Metabolism to KATP Channels in the Heart , 2001, Circulation research.
[40] A. Terzic,et al. Quaternary structure of KATP channel SUR2A nucleotide binding domains resolved by synchrotron radiation X-ray scattering. , 2010, Journal of structural biology.
[41] A. Terzic,et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation , 2007, Nature Clinical Practice Cardiovascular Medicine.
[42] J. Bryan,et al. A Family of Sulfonylurea Receptors Determines the Pharmacological Properties of ATP-Sensitive K+ Channels , 1996, Neuron.
[43] A. Terzic,et al. Kir6.2 is required for adaptation to stress , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[44] A. Terzic,et al. Stress without distress: homeostatic role for KATP channels , 2003, Molecular Psychiatry.
[45] J. Weiss,et al. Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Network perspectives of cardiovascular metabolism Published, JLR Papers in Press, August 31, 2006. , 2006, Journal of Lipid Research.
[46] G. Gross,et al. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. , 1992, Circulation research.
[47] B. Soria,et al. Intracellular location of KATP channels and sulphonylurea receptors in the pancreatic beta-cell: new targets for oral antidiabetic agents. , 2004, Current medicinal chemistry.
[48] A. Terzic,et al. Sarcolemmal ATP-sensitive K(+) channels control energy expenditure determining body weight. , 2010, Cell metabolism.
[49] Mark E. J. Newman,et al. The Structure and Function of Complex Networks , 2003, SIAM Rev..
[50] C. Davies,et al. Ion channels : from structure to function , 2010 .
[51] Ralf Kettenhofen,et al. Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium , 2006, The Journal of experimental medicine.
[52] Christine L. Mummery,et al. Embryonic Stem (es) Cells from Mice and Primates Can Differentiate into Any Cell Type in the Adult Body Stem Cells in Fetal and Adult Hearts Stem-cell-based Therapy and Lessons from the Heart Insight Review , 2022 .
[53] J. Bell. Predicting disease using genomics , 2004, Nature.
[54] Ali G. Gharavi,et al. Molecular Mechanisms of Human Hypertension , 2001, Cell.
[55] K. Chien,et al. Stress Pathways and Heart Failure , 1999, Cell.
[56] Leroy Hood,et al. The impact of systems approaches on biological problems in drug discovery , 2004, Nature Biotechnology.
[57] D. K. Arrell,et al. ATP-sensitive K+ channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility. , 2009, Journal of proteome research.
[58] W. Coetzee,et al. The Glycolytic Enzymes, Glyceraldehyde-3-phosphate Dehydrogenase, Triose-phosphate Isomerase, and Pyruvate Kinase Are Components of the KATP Channel Macromolecular Complex and Regulate Its Function* , 2005, Journal of Biological Chemistry.
[59] João Ferreira-Martins,et al. Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function , 2010, Circulation.
[60] Yuan-Ping Pang,et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating , 2004, Nature Genetics.
[61] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[62] Lila R Collins,et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.
[63] I. Stagljar,et al. Glyceraldehyde 3‐phosphate dehydrogenase serves as an accessory protein of the cardiac sarcolemmal KATP channel , 2005 .
[64] Richard T. Lee,et al. Stem-cell therapy for cardiac disease , 2008, Nature.
[65] J. Kostis. From hypertension to heart failure: update on the management of systolic and diastolic dysfunction. , 2003, American journal of hypertension.
[66] Bruce D. Johnson,et al. KATP channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response , 2009, Human Genetics.
[67] J. Clement,et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. , 1995, Science.
[68] A. Noma,et al. ATP-regulated K+ channels in cardiac muscle , 1983, Nature.
[69] E. Frohlich,et al. The aging hypertensive heart: a brief update , 2008, Nature Clinical Practice Cardiovascular Medicine.
[70] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[71] Emmanuel Messas,et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study , 2005, The Lancet.
[72] T. Flagg,et al. Muscle KATP channels: recent insights to energy sensing and myoprotection. , 2010, Physiological reviews.
[73] A. Terzic,et al. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[74] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[75] A. Terzic,et al. KATP channels process nucleotide signals in muscle thermogenic response , 2010, Critical reviews in biochemistry and molecular biology.
[76] J. Inazawa,et al. Reconstitution of IKATP: An Inward Rectifier Subunit Plus the Sulfonylurea Receptor , 1995, Science.
[77] S. Seino,et al. Structure and Function of ATP-Sensitive K+ Channels , 2000 .
[78] A. Terzic,et al. Nucleotide-gated KATP channels integrated with creatine and adenylate kinases: Amplification, tuning and sensing of energetic signals in the compartmentalized cellular environment , 2004, Molecular and Cellular Biochemistry.
[79] C. Botting,et al. Creatine kinase is physically associated with the cardiac ATP‐sensitive k+ channel in vivo , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[80] F. Collins,et al. Genomic medicine--an updated primer. , 2010, The New England journal of medicine.
[81] A. Terzic,et al. Human KATP channelopathies: diseases of metabolic homeostasis , 2009, Pflügers Archiv - European Journal of Physiology.
[82] L. Hood,et al. Gene expression dynamics in the macrophage exhibit criticality , 2008, Proceedings of the National Academy of Sciences.
[83] Andre Terzic,et al. Stem Cell Platforms for Regenerative Medicine , 2009, Clinical and translational science.
[84] H. Watkins,et al. Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. , 2007, Journal of the American College of Cardiology.
[85] A. Terzic,et al. Channelopathies: Decoding Disease Pathogenesis , 2010, Science Translational Medicine.
[86] A. Terzic,et al. Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A. , 1999, Journal of molecular and cellular cardiology.
[87] D. K. Arrell,et al. Cardiovascular proteomics: evolution and potential. , 2001, Circulation research.
[88] R. Guyton,et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. , 2004, The Annals of thoracic surgery.
[89] S. Matsuoka,et al. Flk1(+) cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model. , 2007, Cardiovascular research.
[90] A. Terzic,et al. ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart. , 2005, Journal of molecular and cellular cardiology.
[91] D. Noble,et al. Systems biology and the virtual physiological human , 2009, Molecular systems biology.
[92] J. Downey,et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. , 2004, Journal of the American College of Cardiology.